Investor Notice: Legal Advocate Juan Monteverde Urges Action from Shareholders of GRCL, RYZB, CVLY, and WAVD

Juan Monteverde, the founder and managing partner of Monteverde & Associates PC, is calling for shareholders of GRCL, RYZB, CVLY, and WAVD to take decisive action. As the head of a renowned national securities firm, Monteverde has built a reputation for representing investors in securities fraud and corporate governance. The firm's prominence in this field is reflected in their Top 50 ranking in the ISS Securities Class Action Services Report from 2018-2022.

About the Companies

RayzeBio, Inc. RYZB is a forward-looking company engaged in the development of radiopharmaceutical therapies for the treatment of cancer. With its base of operations in San Diego, California, RYZB is pioneering new methods aimed at significantly improving patient outcomes.

Gracell Biotechnologies Inc. GRCL operates out of Suzhou, China and plays a critical role in the clinical-stage biopharmaceutical landscape. Specializing in innovative cell therapies for the treatment of various cancers, GRCL is at the forefront of medical advancements in the People's Republic of China.

Codorus Valley Bancorp, Inc. CVLY, the parent company of PeoplesBank, is deeply rooted in community banking services. Located in York, Pennsylvania, CVLY is committed to providing reliable and comprehensive financial solutions to its community.

Investor Alert

In light of recent developments, the legal expertise of Juan Monteverde has become relevant for shareholders in these companies. As changes and challenges in the financial landscape continue, investor vigilance is increasingly important. It is under this context that Monteverde feels urgent steps need to be taken to protect the investments and rights of shareholders in GRCL, RYZB, CVLY, and WAVD.

Consequences for Inaction

Monteverde warns that failure to act proactively could potentially result in adverse outcomes for investors' financial interests. The call to action is not just a recommendation, but a crucial step in ensuring that shareholders' investments are defended against any improper practices and that corporate governance is conducted ethically.

Investment, Shareholders, Alert